| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/08/2007 | US20070054410 Dithio compounds |
| 03/08/2007 | US20070054409 Urea concentration identification device for urea solution |
| 03/08/2007 | US20070054408 Microfabricated two-pin system for biomolecule crystallization |
| 03/08/2007 | US20070054407 Mass spectrometric analysis of ligand conjugated magnetic nanoparticles |
| 03/08/2007 | US20070054406 Meter for rapid analysis of unbound zinc in liquids |
| 03/08/2007 | US20070054405 Patient sample classification based upon low angle light scattering |
| 03/08/2007 | US20070054404 Method of hemoglobin correction due to temperature variation |
| 03/08/2007 | US20070054403 Method of preventing white blood cell interferences to red blood cell measurements of a blood sample |
| 03/08/2007 | US20070054392 Method for characterizing a surface, and device therefor |
| 03/08/2007 | US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 03/08/2007 | US20070054361 Compositions and methods for the diagnosis and treatment of tumor |
| 03/08/2007 | US20070054345 Expression quantification using mass spectrometry |
| 03/08/2007 | US20070054344 Novel fructosyl peptide oxidase and utilization thereof |
| 03/08/2007 | US20070054341 Immunoassay and reagents and kits for performing the same |
| 03/08/2007 | US20070054340 Method and antibodies for detecting nitrofuran |
| 03/08/2007 | US20070054339 detection of binding or cleavage of specific binding substances to biosensor surfaces consisting of microtiter wells or plates, test tube, petri dish and microfluidic channels; immobilization/biochemical; high throughput assay |
| 03/08/2007 | US20070054338 Single receptor assays for immunosuppressive drugs |
| 03/08/2007 | US20070054337 Nanoparticle conjugates and method of production thereof |
| 03/08/2007 | US20070054336 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 03/08/2007 | US20070054335 analysis apparatus comprising of strips having mycobacterial antigen cocktail consisting of early secretory antigen targets(ESAT-6), culture filtrate proteins(CFP10) and mycobacterial protein(MPB83) antigens, fragments or fusion proteins, used for detecting antibodies to mycobacterium antigens in mammals |
| 03/08/2007 | US20070054334 free surface antigens of the organism may be used to determine the presence of infection in an animal caused by the organism by determining the presence of antibodies that bind to the free surface antigens in a sample obtained from the animal |
| 03/08/2007 | US20070054333 for identification on human chromosome 10 of a tumor suppressor gene; |
| 03/08/2007 | US20070054332 Syndecan 1 ectodomain inhibits cancer |
| 03/08/2007 | US20070054331 System and method of evaluation of stochastic interactions of a soluble ligand with a target cell population for optimization of drug design and delivery |
| 03/08/2007 | US20070054330 determining whether a biological sample comprising human lung cancer cells is sensitive to a combination of an epidermal growth factor receptor inhibitor and a chemotherapeutic agent by determining the overexpression of a phosphorylated AKT protein |
| 03/08/2007 | US20070054329 Biomarker for ovarian and endometrial cancer: hepcidin |
| 03/08/2007 | US20070054328 Methods |
| 03/08/2007 | US20070054327 Cell observation apparatus |
| 03/08/2007 | US20070054326 Antibody-based protein array system |
| 03/08/2007 | US20070054325 Materials and methods for screening modulators of neural regeneration |
| 03/08/2007 | US20070054324 CAT1 transporters expressed in blood brain barrier cells |
| 03/08/2007 | US20070054323 screening for therapeutic, cytotoxic or imaging compounds that can be transported through the blood brain barrier and used in the treatment or diagnosis of neurological diseases; organic cation transporter (OCT3) |
| 03/08/2007 | US20070054322 Methods and kits for the detection of prion diseases |
| 03/08/2007 | US20070054321 Methods of diagnosing and treating inflammatory diseases using pac-1 (dusp2) |
| 03/08/2007 | US20070054320 Cytokine zalpha11 ligand antibodies |
| 03/08/2007 | US20070054319 Light-activated cation channel and uses thereof |
| 03/08/2007 | US20070054318 Soluble low-density lipoprotein receptor related protein binds directly to alzheimer's amyloid-beta peptide |
| 03/08/2007 | US20070054317 Electrochemical affinity biosensor system and methods |
| 03/08/2007 | US20070054316 Radical activated cleavage of biologics and microfluidic devices using the same |
| 03/08/2007 | US20070054315 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for producing the complex structure |
| 03/08/2007 | US20070054314 Adiponectin receptor and gene encoding the same |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/08/2007 | US20070054309 Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease |
| 03/08/2007 | US20070054308 Fluorescence polarization assay |
| 03/08/2007 | US20070054307 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 03/08/2007 | US20070054304 used in binding and detecting immobilized and solubilized phosphorylated target molecules, isolation of phosphorylated target molecules from a complex mixture and aiding in proteomic analysis wherein kinase and phosphatase substrates and enzymes can be identified |
| 03/08/2007 | US20070054290 Bind to hedgehog polypeptides with high affinity; exhibit spatially and temporally restricted expression domains indicative of important roles in hedgehog-mediated induction |
| 03/08/2007 | US20070054284 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 03/08/2007 | US20070054277 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 03/08/2007 | US20070054273 Microarray devices having controllable reaction volume |
| 03/08/2007 | US20070054271 Gene expression in breast cancer |
| 03/08/2007 | US20070054270 Preloaded microfluidic devices |
| 03/08/2007 | US20070054268 Methods of diagnosis and prognosis of ovarian cancer |
| 03/08/2007 | US20070054266 Chemical sensor system |
| 03/08/2007 | US20070054262 Methods of identifying optimal variants of peptide epitopes |
| 03/08/2007 | US20070054260 Pharmacodynamic assays |
| 03/08/2007 | US20070053962 Diagnostic markers of wound infection III |
| 03/08/2007 | US20070053961 Diagnostic markers of wound infection II |
| 03/08/2007 | US20070053928 Compounds useful in the diagnosis and treatment of pregnancy-associated malaria |
| 03/08/2007 | US20070053926 Antigenic neisserial peptides |
| 03/08/2007 | US20070053925 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 03/08/2007 | US20070053921 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| 03/08/2007 | US20070053916 Plasmodium falciparum peptide for use in stimulating immune response to treat and prevent malaria |
| 03/08/2007 | US20070053915 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 03/08/2007 | US20070053914 Antitumor antibodies, proteins, and uses thereof |
| 03/08/2007 | US20070053913 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2) |
| 03/08/2007 | US20070053911 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) |
| 03/08/2007 | US20070053910 Modulation of s6 kinase activity for the treatment of obesity |
| 03/08/2007 | US20070053908 Uses of human zven antagonists |
| 03/08/2007 | US20070053907 Uses of human zven antagonists |
| 03/08/2007 | US20070053904 Antibodies having diagnostic, preventive, therapeutic, and other uses |
| 03/08/2007 | US20070053896 Diagnostic marker for ovarian cancer |
| 03/08/2007 | US20070053891 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 03/08/2007 | US20070053885 Mesenchymal stem cell |
| 03/08/2007 | US20070053836 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/08/2007 | US20070053831 Methods for binding agents to b-amyloid plaques |
| 03/08/2007 | US20070053569 Method and apparatus for automated image analysis of biological specimens |
| 03/08/2007 | US20070051815 Optically encoded particles with grey scale spectra |
| 03/08/2007 | US20070051193 In-situ seal integrity monitoring |
| 03/08/2007 | US20070051162 Artificial throat |
| 03/08/2007 | DE202006016697U1 Assay für Lanthanhydroxycarbonat Assay for Lanthanhydroxycarbonat |
| 03/08/2007 | DE202005020939U1 Kit zur Messung der Aktivierung neutrophiler Zellen A kit for measuring the activation of neutrophils |
| 03/08/2007 | DE19958198B4 Mit dem IGF-1 Rezeptor wechselwirkende Proteine (IIPs) With the IGF-1 receptor interacting proteins (IIPs) |
| 03/08/2007 | DE10308975B4 Vorrichtung und Verfahren zur Detektion einer Substanz Apparatus and method for detecting a substance |
| 03/08/2007 | DE102005042544A1 Beeinflussung des kardialen Fc-Rezeptors zur Behandlung der dilatativen Kardiomyopathie Influencing the cardiac Fc receptor for the treatment of dilated cardiomyopathy |
| 03/08/2007 | DE102005042492A1 Measurement device for determining objects in non-water fluids that consists of a measurement electrode to establish the first parameter and measuring element to determine the second parameter |
| 03/08/2007 | DE102005042133A1 Verfahren zur Diagnose von Sepsis mit Apolipoprotein A1 A method for diagnosis of sepsis with apolipoprotein A1 |
| 03/08/2007 | DE102005042132A1 Method for diagnosis, assessment and monitoring of sepsis or generalized inflammation, comprises measuring content of immunoglobulin M in a patient sample |
| 03/08/2007 | DE102005042100A1 Method for diagnosis, assessment and monitoring of sepsis or generalized inflammation, comprises measuring content of haptoglobin-related protein in a patient sample |
| 03/08/2007 | DE102005041782A1 Fabric arrays e.g. tissue micro arrays, manufacturing device, has hollow needle for producing hollow space in receiver block, another needle for taking out specimen from fabric, and pantograph for positioning needles over receiver block |
| 03/08/2007 | DE102005041781A1 Tissue array production device e.g. tissue microarrays, has positioning array for positioning of first and second hollow needles whereby mobile pivotable transmits position of markings on donor block and receiver block |
| 03/08/2007 | DE102005041780A1 Vorrichtung zur Herstellung von Gewebearrays An apparatus for the production of tissue arrays |
| 03/08/2007 | CA2658326A1 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue |
| 03/08/2007 | CA2625940A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 03/08/2007 | CA2621144A1 Human g protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to mcp-1 expression |
| 03/08/2007 | CA2621137A1 Biocompatible n,n-disubstituted sulfonamide-containing fluorescent dye labels |
| 03/08/2007 | CA2621070A1 Composition and method for diagnosing kidney cancer and estimating kidney cancer patient's prognosis |
| 03/08/2007 | CA2621060A1 Kit and method for detection of urothelial cancer |
| 03/08/2007 | CA2621017A1 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 03/08/2007 | CA2620936A1 Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics |